Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.

Saved in:
Bibliographic Details
Title: Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
Authors: Nishri Y; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Vatarescu M; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Luz I; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Epstein L; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Radiation Protection Department, Soreq Nuclear Research Center, Yavne, Israel.; Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel., Dumančić M; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Del Mare S; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Shai A; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Schmidt M; Physics Laboratory, Alpha Tau Medical, Jerusalem, Israel., Deutsch L; Biostatistics Department, BioStats Statistical Consulting Ltd., Maccabim, Israel., Den RB; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; Department of Radiation Oncology, Urology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Kelson I; School of Physics and Astronomy, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel., Keisari Y; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Arazi L; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Cooks T; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Domankevich V; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
Source: Frontiers in oncology [Front Oncol] 2022 Sep 27; Vol. 12, pp. 888100. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.888100